LogicMark Past Earnings Performance
Past criteria checks 0/6
LogicMark's earnings have been declining at an average annual rate of -34.4%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been declining at an average rate of 12.5% per year.
Key information
-34.4%
Earnings growth rate
-0.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -12.5% |
| Return on equity | -97.6% |
| Net Margin | -158.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing LogicMark, Inc.'s (NASDAQ:LGMK) CEO Pay Packet
Dec 14
LogicMark, Inc.'s (NASDAQ:LGMK) Business And Shares Still Trailing The Industry
Jul 21LogicMark stock gains on strong Q2 earnings
Aug 12Companies Like LogicMark (NASDAQ:LGMK) Are In A Position To Invest In Growth
Mar 04Nxt-ID (NASDAQ:NXTD) Is In A Good Position To Deliver On Growth Plans
Nov 18Health Check: How Prudently Does Nxt-ID (NASDAQ:NXTD) Use Debt?
Jul 19NXT-ID appoints Chia-Lin Simmons as CEO
Jun 17Nxt-ID prepays $3M of senior secured term loan facility
May 03A Look At The Fair Value Of Nxt-ID, Inc. (NASDAQ:NXTD)
Mar 29Nxt-ID (NASDAQ:NXTD) Shareholders Have Enjoyed A Whopping 346% Share Price Gain
Mar 01Here's Why Nxt-ID (NASDAQ:NXTD) Is Weighed Down By Its Debt Load
Jan 29
A Look At The Fair Value Of Nxt-ID, Inc. (NASDAQ:NXTD)
Dec 24Does Nxt-ID (NASDAQ:NXTD) Have The Makings Of A Multi-Bagger?
Nov 19Revenue & Expenses BreakdownBeta
How LogicMark makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 10 | -16 | 12 | 1 |
| 30 Sep 23 | 10 | -8 | 12 | 1 |
| 30 Jun 23 | 10 | -9 | 13 | 1 |
| 31 Mar 23 | 11 | -8 | 12 | 1 |
| 31 Dec 22 | 12 | -7 | 12 | 1 |
| 30 Sep 22 | 12 | -11 | 12 | 1 |
| 30 Jun 22 | 12 | -10 | 10 | 1 |
| 31 Mar 22 | 11 | -10 | 8 | 1 |
| 31 Dec 21 | 10 | -14 | 7 | 1 |
| 30 Sep 21 | 10 | -10 | 6 | 1 |
| 30 Jun 21 | 10 | -10 | 7 | 1 |
| 31 Mar 21 | 10 | -10 | 7 | 1 |
| 31 Dec 20 | 11 | -4 | 7 | 1 |
| 30 Sep 20 | 13 | -1 | 7 | 1 |
| 30 Jun 20 | 15 | 0 | 7 | 1 |
| 31 Mar 20 | 17 | -2 | 8 | 1 |
| 31 Dec 19 | 17 | -3 | 9 | 1 |
| 30 Sep 19 | 17 | -3 | 10 | 1 |
| 30 Jun 19 | 17 | -3 | 11 | 1 |
| 31 Mar 19 | 17 | -1 | 11 | 1 |
| 31 Dec 18 | 17 | -1 | 11 | 1 |
| 30 Sep 18 | 17 | -3 | 12 | 1 |
| 30 Jun 18 | 17 | -6 | 13 | 1 |
| 31 Mar 18 | 14 | -9 | 13 | 1 |
| 31 Dec 17 | 16 | -9 | 12 | 1 |
| 30 Sep 17 | 16 | -10 | 11 | 1 |
| 30 Jun 17 | 16 | -10 | 10 | 0 |
| 31 Mar 17 | 14 | -9 | 9 | 1 |
| 31 Dec 16 | 8 | -14 | 9 | 1 |
| 30 Sep 16 | 3 | -15 | 8 | 1 |
| 30 Jun 16 | 1 | -16 | 7 | 2 |
| 31 Mar 16 | 1 | -16 | 7 | 3 |
| 31 Dec 15 | 1 | -13 | 7 | 3 |
| 30 Sep 15 | 1 | -11 | 7 | 3 |
| 30 Jun 15 | 0 | -10 | 6 | 3 |
| 31 Mar 15 | 0 | -9 | 5 | 2 |
| 31 Dec 14 | 0 | -7 | 4 | 1 |
| 30 Sep 14 | 0 | -5 | 3 | 1 |
| 30 Jun 14 | 0 | -3 | 2 | 1 |
| 31 Mar 14 | 0 | -1 | 1 | 1 |
| 31 Dec 13 | 0 | -2 | 1 | 1 |
| 30 Sep 13 | 0 | -1 | 1 | 0 |
| 30 Jun 13 | 0 | -1 | 1 | 0 |
Quality Earnings: LGMK is currently unprofitable.
Growing Profit Margin: LGMK is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LGMK is unprofitable, and losses have increased over the past 5 years at a rate of 34.4% per year.
Accelerating Growth: Unable to compare LGMK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LGMK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: LGMK has a negative Return on Equity (-97.57%), as it is currently unprofitable.